A randomised, double-blind study comparing the efficacy and tolerability of controlled-release doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia in Brazil

Brazilian patients with benign prostatic hyperplasia were randomised in a 12-week, double-blind, double-dummy study to receive doxazosin gastrointestinal therapeutic system (GITS) 4 mg q.i.d. (n = 82) or tamsulosin 0.4 q.i.d. (n = 83). Primary endpoints were the absolute and percentage change from b...

Descripción completa

Detalles Bibliográficos
Autores principales: POMPEO, A C L, ROSENBLATT, C, BERTERO, E, DA ROS, C T, CAIROLI, C E D, DAMIÃO, R, WROCLAWSKI, E R, KOFF, W J, MESQUITA, F, PINHEIRO, G E
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2006
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618820/
https://www.ncbi.nlm.nih.gov/pubmed/16942589
http://dx.doi.org/10.1111/j.1742-1241.2006.01107.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618820/
https://www.ncbi.nlm.nih.gov/pubmed/16942589
http://dx.doi.org/10.1111/j.1742-1241.2006.01107.x

Ejemplares similares